MEREDITH SPENCER: Open Payments
NPI 1205376167 · RADFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 53 payments from 15 companies in 2025. Trend: 2023 $1,063 · 2024 $910 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $250 |
| Amgen Inc. | 11 | $154 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| PFIZER INC. | 5 | $98 |
| Abbott Laboratories | 4 | $78 |
| Lilly USA, LLC | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| ABBVIE INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: Ozempic, RECORLEV, OTEZLA, FREESTYLE LIBRE 3, NURTEC ODT, MOUNJARO, SPRAVATO, XIFAXAN.
Industry payments across VA — which companies pay providers there.
